Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Glenmark Generics announced that the Food and Drug Administration (FDA) has approved Ashlyna (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Extended-Cycle Oral Contraceptive Tablets, the generic version of Teva Women’s Health’s Seasonique.
Seasonique is an extended-cycle oral contraceptive consisting of a progestin and estrogen. It is indicated for women to prevent pregnancy. Combination oral contraceptives lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.
RELATED: IUD, Contraceptive Implant Use Becoming More Popular Among U.S. Women
Glenmark plans to begin shipping of Ashlyna immediately.
For more information visit GlenmarkPharma.com.
